2014 ACR/ARHP Annual Meeting Archives - Page 192 of 202

Abstract Number: 938

C1q Is Mandatory for Disease Development in Experimental Arthritis and Expression of Its Receptors Correlates with Disease Activity in Patients
Abstract Number: 2798

C5orf30 a Novel Regulator of Inflammation and Tissue Damage in Rheumatoid Arthritis
Abstract Number: 1462

Cadherin-11 mRNA Expression in the Peripheral Blood of Rheumatoid Arthritis Patients As a Marker of Active Polyarthritis
Abstract Number: 528

Calcium-Calcineurin-NFAT Signaling Pathway Regulates AQP5 Expression in Primary Salivary Gland Acinar Cells
Abstract Number: 2988

Calgranulin Levels Are Elevated in Spondyloarthritis and Reflect the Presence of Acute Microscopic Gut Inflammation
Abstract Number: 2926

Calprotectin Serum Levels Reflect Residual Inflammatory Activity in Patients with Rheumatoid Arthritis and Psoriatic Arthritis on Clinical Remission or Low Disease Activity Undergoing TNF-Antagonists Therapy
Abstract Number: 2846

CaMK4 Inhibition Ameliorates the Development of Th17 Driven Inflammatory Diseases By Preventing Recruitment of IL-17 Producing Cells to Target Organs
Abstract Number: 1875

Can Allopurinol Survival Impact Reverse Depending on Patients’ Characteristics? a Propensity-Score-Based Subgroup Analysis
Abstract Number: 1868

Can DAS 28 at 3 Months after the 1^st Biologic Therapy Predict Subsequent Sustainable Clinical Remission in Polyarticular Juvenile Idiopathic Arthritis Patients?
Abstract Number: 402

Can GP88 (Progranulin) be Used As a Biomarker for the Diagnosis and Therapy Evaluation of Rheumatoid Arthritis?
Abstract Number: 3007

Can Knee Pain be Prevented through Diet and Exercise Among Those at High Risk? the Look Ahead Study
Abstract Number: 1490

Can Tumor Necrosis Factor Inhibitors Protect Rheumatoid Arthritis Patients from Osteoporosis? Impact of Tumor Necrosis Factor Inhibitors on Bone Mineral Density and Bone Remodeling Markers
Abstract Number: 138

Can Ultrasonography of Peripheral Entheses Play a Role in the Diagnosis and Understanding of Diffuse Idiopathic Skeletal Hyperostosis (DISH)?
Abstract Number: 157

Can We Diagnose Acute Gout without Joint Aspiration? Results of a Prospective Study of 112 Patients Presenting with Acute Arthritis
Abstract Number: 1097

Can We Help Identify Learning Disabilities in Fibromyalgia Patients?
Abstract Number: 120

Can We Use Ultrasound to Identify Rheumatoid Arthritis Patients in Remission Who Cannot Taper Their Medication?
Abstract Number: 2291

Canakinumab in Biologic-naïve Versus Previously Biologic-Exposed Systemic Juvenile Idiopathic Arthritis Patients: Efficacy Results from a 12 Week Pooled Post Hoc Analysis
Abstract Number: 159

Canakinumab in Frequently Flaring Gouty Arthritis Patients, Contraindicated, Intolerant or Unresponsive to non-Steriodal Anti-Inflammatory drugs and/or Colchicine: Safety and Efficacy Results from Long Term Follow-up
Abstract Number: 1232

Canakinumab Therapy in Patients with Familial Mediterranean Fever
Abstract Number: 2298

Canakinumab Treatment Shows Maintained Efficacy in Systemic Juvenile Idiopathic Arthritis (SJIA) Patients at Individual Patient Level: An Analysis of 12 Week Pooled Data
Abstract Number: 833

Canakinumab Use in Patients with Cryopyrin-Associated Periodic Syndrome: Interim Safety and Efficacy Results from Beta-Confident Registry
Abstract Number: 853

Cancer Incidence in TNF Inhibitor Treated Patients with Axial Spondyloarthritis and Psoriatic Arthritis – a Study from the ARTIS and Danbio Registers
Abstract Number: 1768

Cardiac Involvement in Granulomatosis with Polyangiitis: A Magnetic Resonance Imaging Study of 31 Consecutive Patients
Abstract Number: 2641

Cardiac Magnetic Resonance Imaging in Systemic Lupus Erythematosus
Abstract Number: 1322

Cardiopulmonary Involvement in Juvenile Systemic Sclerosis: Development of Recommendations for Screening and Investigation
Abstract Number: 2307

Cardiovascular Disease Prevention in Rheumatologic Disease: Assessing Screening in a Primary Care Setting
Abstract Number: 564

Cardiovascular Events in Ankylosing Spondylitis. an Updated Meta-Analysis
Abstract Number: 865

Cardiovascular Events Prior to or Early after Diagnosis of SLE
Abstract Number: 1367

Cardiovascular Morbidity and Associated Risk Factors in Spanish Patients with Chronic Inflammatory Rheumatic Diseases Attending Rheumatology Clinics
Abstract Number: 1423

Cardiovascular Risk Estimation in Rheumatoid Arthritis: What Is Missing in Traditional Risk Estimators?
Abstract Number: 787

Cardiovascular Risk Factors and Incident Giant Cell Arteritis
Abstract Number: 839

Cardiovascular Risk with Nsaids in Rheumatoid Arthritis: An Analysis Using Routinely Collected Data
Abstract Number: 1359

Care of Women with Rheumatological Conditions during Family Planning and Pregnancy
Abstract Number: 2644

Carotid Intima-Media Thickness and Plaque in Mexican Mestizos with Systemic Lupus Erythematosus: A Case-Control Study
Abstract Number: 2080

Carryover Effects in Crossover Design Studies in Fibromyalgia and Other Pain Conditions
Abstract Number: 2287

Cartilage Thickness and Bone Health in Children with Juvenile Idiopathic Arthritis
Abstract Number: 969

Caspase-8 Prevents Lung Fibrosis in a Murine SSc-like Disease Model By Preventing Macrophage Differentiation
Abstract Number: 1010

Catecholaminergic-to-Cholinergic Transition of Sympathetic Nerve Fibers in Arthritis and in a Co-Culture System of Sympathetic Ganglia in Vitro
Abstract Number: 836

Categorical Change in 6MWD in Patients with Connective Tissue Disease Associated Pulmonary Arterial Hypertension Receiving Ambrisentan over 3-Years
Abstract Number: 2666

Causes of Stillbirths in Women with SLE
Abstract Number: 763

Caveolin-1 and Peroxisome Proliferator-Activated Receptor Gamma Co-Regulate the Differentiation of Monocytes to Adipocytes and Myofibroblasts in Vivo and in Vitro
Abstract Number: 1748

CCR6⁺CD4⁺ Cells Are Counterparts of Follicular T-Cells Supporting Autoantibody Production in Rheumatoid Arthritis
Abstract Number: 1863

CCX168, an Orally Administered C5aR Inhibitor for Treatment of Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Abstract Number: 27

CD115⁺ Osteoclast Precursors Arise before Clinical Onset of Arthritis and Are Regulated By Proinflammatory Cytokines
Abstract Number: 1946

CD22 Is Required for Formation of Memory B Cell Precursors within Germinal Centers
Abstract Number: 2743

CD27 Is a Key Regulator of T Cell Responses
Abstract Number: 2726

CD28null T Cells from Polymyositis Patients Are Cytotoxic to Autologous Muscle Cells in Vitro Via Perforin-Dependent Mechanisms
Abstract Number: 1752

CD30 As a Target of Aptamers and Delivery Portal for Aptamer-shRNA to Block Th17 Cells
Abstract Number: 1751

CD4 Aptamer-RORγt shRNA Chimera Inhibits IL-17 Synthesis By Human CD4⁺ T cells
Abstract Number: 1744

CD4+ T Cell Subpopulations in Blood and Synovial Fluid Defined By Differential Expression of Integrins
Abstract Number: 1631

Cell Bound Complement Activation Products and Their Relationship to Disease Activity and Quality of Life Measures in Systemic Lupus Erythematosus
Abstract Number: 1924

Cell Bound Complement Activation Products Have Higher Sensitivity Than Serum C3 and C4 Levels in Systemic Lupus Erythematosus
Abstract Number: 80

Cellular Responses of IL6 Inhibition (Tocilizumab) in Rheumatoid Arthritis Using High-Accuracy Tandem Mass Spectrometry
Abstract Number: 2462

Centrosomal Protein 70kDa Is Down-Regulated By Decoy Receptor 3 in Specifically Rheumatoid Synovial Fibroblasts
Abstract Number: 2655

Cerebral Small Vessel Disease in Systemic Lupus Erythematosus: Histopathological Study
Abstract Number: 2827

Cervical Spine Fracture and Mortality in Ankylosing Spondylitis
Abstract Number: 2359

CGEN-15001, a Novel Immunomodulatory Fusion Protein of the B7 Family Induces Immune Tolerance and Shows Efficacy in Mouse Models of Rheumatoid Arthritis and Psoriasis
Abstract Number: 1903

Change in 14-3-3η Expression in Early RA Patients Treated with Dmards Corresponds with Change in DAS28 and Good EULAR Responses
Abstract Number: 1579

Change in Weight from Baseline with Apremilast, an Oral Phosphodiesterase 4 Inhibitor: Pooled Results from 3 Phase 3, Randomized, Controlled Trials
Abstract Number: 2270

Changes in Cerebral Blood Flow Velocity in Patients with Familial Mediterranean Fever
Abstract Number: 207

Changes in Knee Compartment Distriubtion of Cartilage Loss and Bone Marrow Lesions over 7 Years: The MOST Study
Abstract Number: 2861

Changes in Knee Kinematics from a 6-Week Hip and Trunk Strengthening Program for Persons with Patellofemoral Osteoarthritis
Abstract Number: 1020

Changes in Peripheral Blood Immune Cell Composition in Osteoarthritis
Abstract Number: 2259

Changes in serum Soluble RANKL and Osteoprotegerin Levels after Teriparatide Administration in Rheumatic Disease Patients with Glucocorticoid-Induced Osteoporosis
Abstract Number: 1964

Changes in Soluble CD18 Reflect Latency in the Immune System and Predict Radiographic Progression in Early Rheumatoid Arthritis
Abstract Number: 2254

Changes in Subject Characteristics in the Denosumab Pivotal Fracture Trial and Its Extension for up to 8 Years
Abstract Number: 1435

Changes in the Types and Prognoses of Infections Complicated in RA Patients during the Last 15 Years, in Japan.
Abstract Number: 604

Characterisation of Mucosal-Associated Invariant T (MAIT) Cells in Ankylosing Spondylitis Patients
Abstract Number: 2806

Characteristic Phenotype of Peripheral Blood Lymphocytes in Patients with IgG4-Related Disease, Comparing to Primary Sjögren Syndrome and Healthy Controls
Abstract Number: 2245

Characteristics of Conventional Footwear and Their Association with Reductions in Knee Loading with a Flexible Footwear Intervention
Abstract Number: 707

Characteristics of Lupus Patients with Interstitial Lung Disease and Relationship with Jo-1 Antibody
Abstract Number: 2124

Characteristics of Medicare Beneficiaries Travelling Long Distances to Visit a Rheumatologist
Abstract Number: 924

Characteristics of Pain Flares in Knee Osteoarthritis
Abstract Number: 256

Characteristics of Pain in Fabry Disease
Abstract Number: 2532

Characteristics of Primary Sjögren Syndrome in the Black Population of Martinique
Abstract Number: 2498

Characteristics of Responding Versus Non-Responding Moderate Rheumatoid Arthritis Patients Treated with Etanercept Plus Methotrexate
Abstract Number: 2415

Characteristics of Rheumatoid Arthritis Patients Not Receiving Early Initiation of Disease Modifying Therapy
Abstract Number: 1065

Characteristics of Rheumatoid Arthritis Patients with and without Cardiovascular Diseases – Data from the Ontario Best Practice Research Initiative (OBRI)
Abstract Number: 2672

Characteristics of the Reproductive System in Systemic Lupus Erythematosus: A Cross-Sectional Survey with Pair-Matched Controls
Abstract Number: 1499

Characterization of ABT-494, a Second Generation Jak1 Selective Inhibitor
Abstract Number: 634

Characterization of CD4⁺ T Cell Response and Effects of Regulatory T Cells in Pristane Induced Lupus (PIL)
Abstract Number: 434

Characterization of Lung Inflammation in the Lungs of Early Rheumatoid Arthritis
Abstract Number: 1670

Characterization of Patients with Lupus Nephritis Included in a Large Cohort from the Spanish Society of Rheumatology Registry of Patients with Systemic Lupus Erythematosus
Abstract Number: 2107

Characterization of Social Stigma in Rheumatic Diseases and Correlation with Quality of Life and Medication Adherence
Abstract Number: 2978

Characterization of the Sjögren’s Syndrome Intergenic Non-Coding RNA 1 (SSINCR1)
Abstract Number: 1965

Characterization of the Thyroid Hormone System in Rheumatoid Arthritis
Abstract Number: 1961

Chemokine-like Receptor 1 (CMKLR1) is Expressed on Synoviocytes and Proinflammatory Monocytes in Arthritis and is Predominantly Regulated By β arrestin 2 and G Protein Coupled Receptor Kinase (GRK) 6
Abstract Number: 2155

Chikungunya Fever in Patients Under Biologics
Abstract Number: 1869

Child Pain, Function, and Psychological Outcomes in an Intensive Interdisciplinary Pediatric Pain Rehabilitation Program
Abstract Number: 2629

Childhood-Onset and Adult-Onset Systemic Lupus Erythematosus: Distinctions in an Underserved Ethnic Minority Cohort
Abstract Number: 1295

Childhood-Onset Systemic Lupus Erythematosus: Short-Term Treatment Response Rates in Proliferative Lupus Nephritis
Abstract Number: 1870

Children and Parent Satisfaction in the Pediatric Rheumatology Clinic: Patient Orientated Quality Service Measures
Abstract Number: 1437

Cholesterol Efflux Capacity of HDL and Coronary Atherosclerosis in Rheumatoid Arthritis
Abstract Number: 1208

Cholesterol Loading Induces Neutrophil Extracellular Traps, and Atorvastatin Attenuates This Effect
Abstract Number: 1341

Choosing Not so Wisely: The Tale of Antinuclear Antibody Testing
Abstract Number: 1340

Choosing Subserologies Wisely: An Opportunity for Rheumatologic Healthcare Resource Savings
Abstract Number: 251

Chronic Fatigue Is Associated with Hypoperfusion of Parahippocampal Gyrus
Abstract Number: 975

Chronic Pain Predicts Reduced Physical Activity in a Large Population Cohort Study
Abstract Number: 1023

Chronic PTHrP Treatment Promotes Hypertrophic Differentiation and Inflammatory Gene Expression in Chondrocytes
Abstract Number: 2071

Chronic Widespread Pain Versus Multi-Site Pain: Does the Distribution Matter?
Abstract Number: 154

Cimt in Individuals with Rheumatoid Arthritis Compared to Individuals with Type2 Diabetes
Abstract Number: 423

Circulating Anti-Citrullinated Peptide Antibodies and Cytokines As Biomarkers of Response to Disease-Modifying Antirheumatic Drugs Therapy in Early Rheumatoid Arthritis
Abstract Number: 692

Circulating Anti-Ro/SSA Antibodies Are Associated with the Presence of Severe Mitral Regurgitation in Systemic Lupus Erythematosus
Abstract Number: 2020

Circulating Carotenoids and Subsequent Risk of Rheumatoid Arthritis
Abstract Number: 1950

Circulating CD19⁺CD38⁺CD43⁺ B Cell Subset in SLE Patients Have More Cell Cycle Related Genes Than Healthy Controls
Abstract Number: 1215

Circulating Mediators of Bone Remodeling in Patients with Tophaceous Gout
Abstract Number: 1613

Circulating microRNAs As Candidate Biomarkers of Diagnosis in Systemic Lupus Erythematosus
Abstract Number: 1953

Circulating Plasmablasts from Patients with Systemic Lupus Erythematosus Produce Autoantibodies Reactive to Epstein-Barr Virus
Abstract Number: 1897

Circulating T-Helper Cell- Associated Cytokines and Chemokines in Localized Scleroderma
Abstract Number: 361

Citrullinated 14-3-3η Antibodies Are Specific for Early and Established RA and Are Complementary to ACPA
Abstract Number: 449

Citrullinated-Vimentin-Specific Regulatory T-Cell Responses Associate with ACPA Positive Individuals with Non-Specific Musculoskeletal Symptoms
Abstract Number: 448

Citrulline-Specific Autoimmunity Resides in Quiescent Circulating Memory B Cells in Rheumatoid Arthritis
Abstract Number: 2177

Class a Scavenger Receptor（SR-a）Exacerbated Synovial Fibroblasts-Mediated Inflammation in Rheumatoid Arthritis
Abstract Number: 2302

Classification of Juvenile Spondyloarthropathies According to ASAS Criteria
Abstract Number: 1289

Classification of Osteoarthritis Phenotypes By Metabolomics Analysis
Abstract Number: 2186

Clinical and Immunologic Correlates in Cocaine Users with Serum Anti-Neutrophil Cytoplasmic Antibodies
Abstract Number: 1764

Clinical and Other Differences Observed Between Cocaine Induced and Non-Cocaine Induced Anti-Neutrophil Cytoplasmic Antibody Positive Vasculitis
Abstract Number: 592

Clinical and Psychological Correlates of Sleep Difficulties in Patients with Spondyloarthropathies Compared to Patients with Rheumatoid Arthritis
Abstract Number: 2904

Clinical and Radiological Features of Down’s Arthropathy
Abstract Number: 1256

Clinical and Temporal Characterization of Anti-Jo-1 Positive Anti-Synthetase Syndrome: Preliminary Results of an International Multicentre Study
Abstract Number: 455

Clinical and Tissue Specificity of Antibodies Against Carbamylated Proteins in Patients with Rheumatoid Arthritis
Abstract Number: 1596

Clinical Characteristics and Outcome of Golimumab Treatment Differs Between Bio-naïve and Patients Previously Exposed to Biologicals. Nationwide Results on Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) and Other Spondylarthritidies (SpA)
Abstract Number: 696

Clinical Characteristics and Outcome of Intestinal Pseudo-Obstruction in Patients with Systemic Lupus Erythematosus
Abstract Number: 2153

Clinical Characteristics and Outcomes in Synovial Fluid Culture ̵ Negative Septic Arthritis
Abstract Number: 2215

Clinical Characteristics and Prognosis of Malignancies Associated with Active Myositis
Abstract Number: 587

Clinical Characteristics of Nonradiographic Axial Spondyloarthritis in Korea: A Comparison with Ankylosing Spondylitis
Abstract Number: 1537

Clinical Characteristics of RA Patients Newly Prescribed Tofacitinib Citrate (tofacitinib) in the United States after Food and Drug Administration Approval: Results from the Corrona US Rheumatoid Arthritis Registry
Abstract Number: 1433

Clinical Characterization of Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease
Abstract Number: 1114

Clinical Effectiveness of Exercise and Corticosteroid Injection for Subacromial Impingement Syndrome: A Randomised Controlled Trial
Abstract Number: 1488

Clinical Efficacy of Add-on Iguratimod Therapy in Patients with Active Rheumatoid Arthritis Despite of Methotrexate ~a Multicenter Registry Study~
Abstract Number: 1098

Clinical Efficacy of the High-Concentration Capsaicin Patch for the Treatment of Carpal Tunnel Syndrome
Abstract Number: 1907

Clinical Evaluation of Anti-Aminoacyl tRNA Synthase Antibodies in Rheumatoid Arthritis Patients
Abstract Number: 2653

Clinical Features in Patients with Anti-Triosephosphate Isomerase Antibody-Positive Neuropsychiatric Systemic Lupus Erythematosus
Abstract Number: 2303

Clinical Observation on Ankylosing Spondylitis Patients with Different Phenotypes
Abstract Number: 2911

Clinical Outcomes of Early RA after 7 Years – Does T2T Approach Overcome Delay of Therapy?
Abstract Number: 2248

Clinical Outcomes, Neuropathic Pain and Patient Satisfaction over a 15 Year Period Following Primary Tka: A Repeat-Cross-Sectional Analysis
Abstract Number: 2700

Clinical Phenotype of Systemic Sclerosis Patients with Anti-RNA Polymerase III Antibodies: A New French Cohort, Systematic Review and Meta-Analysis
Abstract Number: 1225

Clinical Presentation and Cytokine Production Abnormalities in a Cohort of Patients Carrying NLRP12 GENE Variants
Abstract Number: 562

Clinical Response and Remission in Patients with Non-Radiographic Axial Spondyloarthritis after Three Years of Adalimumab Therapy
Abstract Number: 1557

Clinical Response in Subjects with Psoriatic Arthritis Following One Year of Treatment with Brodalumab, an Anti-Interleukin-17 Receptor Antibody
Abstract Number: 309

Clinical Significance of Cytokine Profile with Interleukin-18 and -6 in Systemic Juvenile Idiopathic Arthritis
Abstract Number: 2885

Clinical Training Opportunities in Two Innovative Ambulatory Resources: The Primary Care Musculoskeletal Clinic and Center of Excellence Multidisciplinary Clinic
Abstract Number: 400

Clinical Utility of 14-3-3η in the Evaluation of Inflammatory Arthritis
Abstract Number: 2924

Clinical Utility of Random Anti-TNF Drug Level Testing and Measurement of Anti-Drug Antibodies on Long-Term Treatment Response in Rheumatoid Arthritis
Abstract Number: 596

Clinical Value of ASDAS Index in Spanish Patients with Ankylosing Spondylitis
Abstract Number: 1792

Clinical-Biological and Pathological Spectrum and Outcome of IgA Vasculitis in Adults: A French Study
Abstract Number: 2777

Clinical-Biological Spectrum and Therapeutic Management of Hypocomplementemic Urticarial Vasculitis: Data from a French Nationwide Study on 57 Patients
Abstract Number: 2581

Clinically Active Non-Radiographic Axial Spondyloarthritis Patients Who Initially Have a Negative MRI and Normal CRP May Develop a Positive MRI or Elevated CRP at a Later Timepoint
Abstract Number: 2900

Clinically Inactive Disease in Juvenile Dermatomyositis – a Proposed Revision to the Pediatric Rheumatology International Trials Organisation Criteria
Abstract Number: 686

Clinicians Approaches to the Management of Background Therapy in SLE Patients in Clinical Remission: Results of an International Survey
Abstract Number: 2790

CMR with Quantitative T2 Mapping in Patients with Active SLE
Abstract Number: 902

Co-Management for Children with JIA: A Survey of Primary Care Providers Regarding Current Practices and Willingness to Provide Services
Abstract Number: 1053

Co-Morbidity Is Associated with Disease Severity in Early Rheumatoid Arthritis
Abstract Number: 1194

Cofilin-1 Is a ROS Sensor in Regulating the NLRP3 Inflammasome
Abstract Number: 2654

Cognitive Function in Systemic Lupus Erythematosus Patients with Past History of Neuropsychiatric Manifestations : A Longitudinal Study
Abstract Number: 2650

Cognitive Impairment in SLE and Non-Criterion Anti-Phospholipid Antibodies
Abstract Number: 1825

Cognitive Performance Scores for the Pediatric Automated Neuropsychological Assessment Metrics in Childhood-Onset Systemic Lupus Erythematosus
Abstract Number: 2658

Cognitive Symptoms and Associated Disease and Non-Disease Related Factors in Patients with Systemic Lupus Erythematosus : A Longitudinal Study
Abstract Number: 1112

Cognitive Symptoms in Fibromyalgia Patients Compared with Rheumatoid Arthritis Patients
Abstract Number: 247

Cognitive Task Related Hypoperfusion of Frontal Gyrus in Patients with Chronic Fatigue
Abstract Number: 156

Colchicine and the Risk of Acute Cardiovascular (CV) Events Among Gout Patients: The New York Department of Veterans Affairs Retrospective Cohort Study
Abstract Number: 1356

Collaboration Between a Third Party Payer and Community Rheumatologists to Create a Clinical Pathway for the Treatment of Rheumatoid Arthritis to Assure Proper Use of Biologics and Quality of Care
Abstract Number: 541

Collagen II Neo-Epitopes in Spondyloarthritis.
Abstract Number: 794

Color Doppler Ultrasonography Findings in Giant Cell Arteritis and Their Relationship with Clinical Manifestations
Abstract Number: 123

Combination with Joint Power Doppler Signals with Anti-Citrullinated Peptide Antibody Predicts Joint Destruction in Rheumatoid Arthritis
Abstract Number: 2231

Combined Chondroitin Sulfate and Glucosamine Is Comparable to Celecoxib for Painful Knee Osteoarthritis. Results from a Multicenter, Randomized, Double-Blind, PHASE IV NON-Inferiority TRIAL
Abstract Number: 601

Combined Hip Abduction Angle Measured By Using Iphone Compass Application; A Novel Measurement Tool to Asses Hip Mobility
Abstract Number: 638

Commensal Microbiota Influence Systemic Autoimmune Responses
Abstract Number: 2114

Comorbidity Characteristics of Patients Starting First-Line Acute Gout Agents – Colchicine, NSAID, and Corticosteroids
Abstract Number: 1406

Comorbidity in Rheumatoid Arthritis. It Is Feasible to Record Concomitant Medical Conditions and Multi-Morbidity in Observational Research Studies. Can This be Extended to Routine Clinical Settings?
Abstract Number: 1313

Comorbidity Patterns in Children with Juvenile Idiopathic Arthritis and Systemic Lupus Erythematosus: The Childhood Arthritis and Rheumatology Research Alliance Registry
Abstract Number: 2823

Comparable Efficacy with Sarilumab Plus Methotrexate in Biologic-Experienced and Biologic-Naïve Patients with Moderate-to-Severe Rheumatoid Arthritis from a Phase 3, Randomized, Double-Blind, Placebo-Controlled, International Study
Abstract Number: 176

Comparative Cardiovascular (CV) Risk and Outcomes Among Patients with Gout, Osteoarthritis (OA), or Both
Abstract Number: 419

Comparative Dynamics of Rheumatoid Arthritis Disease Activity and Disease Severity Measures Using Rarbis, Ciras and DAS28 in a Population Based Cohort of Patients with RA
Abstract Number: 2265

Comparative Effects of Raloxifene and Bisphosphonate on Bone Mineral Density and Osteoporotic Fracture Outcomes in Rheumatoid Arthritis Patients
Abstract Number: 2853

Comparative Study of Infliximab Versus Adalimumab in Patients with Refractory Uveitis Due to Behçet´s Disease. Multicenter Study of 125 Cases
Abstract Number: 2428

Comparative Study of Rheumatoid Arthritis Disease Activity Indices in Two Populations of Meteor Database
Abstract Number: 2400

Comparing a Tapering Strategy to the Standard Dosing Regimen of TNF Inhibitors in Patients with Rheumatoid Arthritis in Remission or with Low Disease Activity
Abstract Number: 1536

Comparing Abatacept to Adalimumab, Etanercept and Infliximab As First Line Agents in Patients with Rheumatoid Arthritis. Experience from the Rhumadata® Clinical Database and Registry
Abstract Number: 2243

Comparison Between Two Diclofenac Diethylamine Gel Formulations, 1.16% Vs 2.32%: Is It Only Increasing the Strength of the Active Ingredient Enough?
Abstract Number: 1119

Comparison High Intensity Laser Therapy and Wrist Splint in the Treatment of Lateral Epicondylitis
Abstract Number: 1428

Comparison of Application of the European Society Cardiology, Adult Treatment Panel III, and ACC/AHA Guidelines for Cardiovascular Disease Prevention in a French Cohort of Rheumatoid Arthritis
Abstract Number: 553

Comparison of Baseline Extra-Articular Manifestations, Comorbidities, and Long-Term Safety in Patients Treated with Adalimumab for Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
Abstract Number: 440

Comparison of C-Reactive Protein (CRP) and Erythrocyte Sedimentation Rate (ESR) with Estimated Glomerular Filtration Rate (eGFR) in Patients with Rheumatoid Arthritis (RA)
Abstract Number: 96

Comparison of Cardiovascular Risk Factor Management in Patients with RA and Matched Non-RA Patients
Abstract Number: 2616

Comparison of Characteristics of Ankylosing Spondylitis in Association with Familial Mediterranean Fever with Those of Typical Ankylosing Spondylitis
Abstract Number: 826

Comparison of Classification Criteria for Gout Using Monosodium Urate Crystal Identification By a Certified Examiner As the Gold-Standard in a Large Multi-National Study
Abstract Number: 547

Comparison of Clinical and Imaging Characteristics of Axial Psoriatic Arthritis and Axial Spondyloarthritis
Abstract Number: 1329

Comparison of Clinical and Serological Features of Childhood Sjögren Syndrome Based on the Presence or Absence of Parotitis
Abstract Number: 1765

Comparison of Clinical Characteristics of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis By the Serotype Specificity to Myeloperoxidase and Proteinase-3
Abstract Number: 791

Comparison of Clinical Manifestations in Different Histological Subsets of Biopsy-Proven Giant Cell Arteritis
Abstract Number: 1766

Comparison of Clinicopathologically- and Serologically-Based Classification Systems for ANCA-Associated Vasculitis
Abstract Number: 2627

Comparison of Disease Characteristics and Organ Damage in Patients with Juvenile and Adult-Onset Systemic Lupus Erythematosus in Large Cohort from Turkey
Abstract Number: 921

Comparison of Infection Rates in Patients Receiving Denosumab, Denosumab and Biologics and Biologics Alone in a Suburban Rheumatology Clinic
Abstract Number: 2424

Comparison of Medication Use in Rheumatoid Arthritis Patients Between University and Private Settings – Results from Ontario Best Practice Research Initiative
Abstract Number: 2807

Comparison of Outcomes in Septic Arthritis Caused By MRSA and MSSA
Abstract Number: 95

Comparison of Patient Characteristics, Healthcare Costs, and Biologic Persistence Between Patients with Rheumatoid Arthritis Initiating First- or Second-Line Subcutaneous Abatacept, Adalimumab, or Etanercept
Abstract Number: 2426

Comparison of Patient Self-Reported and Physician Reported Rheumatoid Arthritis Medication Use – Results from the Ontario Best Practices Research Initiative
Abstract Number: 2717

Comparison of PROMIS^® survey Between Scleroderma Patients in an Academic Center and Patient-Based Scleroderma Foundations
Abstract Number: 2590

Comparison of Radiographic Damage Score in Ankylosing Spondylitis According to Tumor Necrosis Factor Inhibitor: Observation Study of Korean Spondyloarthropathy Registry (OSKAR) Data
Abstract Number: 717

Comparison of Responsiveness of Lupus Impact Tracker with Lupus Quality of Life to Selena Responder Index
Abstract Number: 1599

Comparison of Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Pregnancies: Disease Activity, Treatment, and Outcomes
Abstract Number: 2688

Comparison of Systemic Lupus Erythematosus and Healthy Anti-Nuclear Antibody Positive African-Americans Reveals Distinct Differences in T Cell and Progenitor Populations
Abstract Number: 3000

Comparison of Systemic Sclerosis Subsets As Predictors of Mortality and Morbidity
Abstract Number: 2365

Comparison of the Effects of a Pharmaceutical Industry Decision Guide and Decision Aids on Patient Choice to Intensify Rheumatoid Arthritis Therapy with Etanercept
Abstract Number: 135

Comparison of the Ultrasonography Images and Synovial Pathology of the Joints in Patients with Rheumatoid Arthritis Treated with Biological Agents
Abstract Number: 1314

Comparison of the Utility and Validity of Three Scoring Tools to Detect Skin Disease in Patients with Juvenile Dermatomyositis
Abstract Number: 1141

Comparisons of Quality of Life, Resource Use and Physical Functioning in RA Patients Classified As High, Moderate or Low Risk for Rapid Radiographic Progression
Abstract Number: 2373

Compliance in the Rheumatoid Arthritis Comparison of Active Therapies Trial: Triple Vs Etanercept
Abstract Number: 473

Complications of Varicella Zona Virus Infections Are More Frequent in Patients Treated with Biologic Drugs When Combined with Steroids
Abstract Number: 461

Comprehensive Summary of the Efficacy and Safety of Tofacitinib 5mg Twice Daily in Patients with Rheumatoid Arthritis and an Inadequate Response to Disease-Modifying Antirheumatic Drugs
Abstract Number: 2553

Compromised Volumetric Bone Density, Bone Microarchitecture and Bone Strength in Patients with Ankylosing Spondylitis: High-Resolution Peripheral Quantitative Computerized Tomography (HRpQCT) Based Study
Abstract Number: 54

Concordance with the National Osteoporosis Foundation Treatment Guidelines After DXA Result Notification
Abstract Number: 2961

Conditional Analysis of 30 Serum Urate Loci Identifies 25 Additional Independent Effects
Abstract Number: 1817

Connecting Two Pathways through Ca²⁺ Signaling: NLRP3 Inflammasome Activation Induced By a Hypermorphic PLCG2 Mutation
Abstract Number: 2276

Consensus Statement on the Transition Process from Pediatric Care to Adult Care in Patients with Chronic Inflammatory Rheumatic Diseases with Childhood-Onset
Abstract Number: 1890

Consistent Inhibition of Bone Destruction By Denosumab in Important Subgroups of Japanese Patients with Rheumatoid Arthritis
Abstract Number: 2330

Construct Validity of the Adult Myopathy Assessment Tool in Individuals with Inclusion Body Myositis
Abstract Number: 2398

Continued Participation in a 10-Year Tight Control Treat-to-Target Study in Rheumatoid Arthritis: Why Keep Patients Doing Their BeSt?
Abstract Number: 2263

Continued Zoledronic Acid Use in a Large Healthcare System
Abstract Number: 2921

Contraceptive Factors Are Associated with Serum Antibodies to Citrullinated Protein Antigens in Women at Elevated Risk for Future Rheumatoid Arthritis
Abstract Number: L9

Contrast Enhanced Ultrasonography in Patients Diagnosed with Early Arthritis: A Preliminary Experience
Abstract Number: 2784

Contribution at the Spinal Level of Innate and Adaptive Immunity to the Development of Persistent Post-Inflammatory Mechanical Allodynia in Arthritic Mice
Abstract Number: 2090

Contribution of MTHFR Gene Polymorphisms in Sjogren’s Syndrome Related Lymphomagenesis
Abstract Number: 2219

Contribution of Tripartite Motif Proteins Modulating Membrane Repair to the Pathogenesis of Autoimmune-Mediated Myositis
Abstract Number: 1189

Conventional Magnetic Resonance Imaging (MR) and Hybrid 18F-Fluoride Positron Emission Tomography MRI (18F-F- PET/MRI) of the Spine and the Sacroiliac Joints – a Detailed Description of Pathologic Signals in Patients with Active Ankylosing Spondylitis
Abstract Number: 2767

Core Outcome Domains and Potential Measurement Instruments in polymyalgia Rheumatica (PMR) Using Omeract Filter 2.0
Abstract Number: 2639

Coronary-Artery Atherosclerosis in Males with Systemic Lupus Erythematosus
Abstract Number: 1338

Correlates of Body Image Dissatisfaction in Patients with Limited and Diffuse Systemic Sclerosis
Abstract Number: 229

Correlates of Heel Bone Mass in Young Adults: The Role of Cholesterol over 20 Years from Childhood to Early Adulthood
Abstract Number: 208

Correlates of Knee Bone Marrow Lesions in Younger Adults
Abstract Number: 2497

Correlation Between Time to Switch and Clinical Response Amplitude to Rituximab in Second Line Treatment in Rheumatoid Arthritis Patients with Treatment Failure to Tumor Necrosis Factor Inhibitors: 3-Year Data from Repeat Observational Study
Abstract Number: 1551

Correlation of Individual HAQ Questions with Disease Activity Measures in Psoriatic Arthritis: Implications for Instrument Reduction
Abstract Number: 2834

Correlation of Laboratory and Clinical Parameters with British Isles Lupus Assessment Group Response in an Open-Label Extension Study of Epratuzumab in Systemic Lupus Erythematosus
Abstract Number: 2813

Correlation of Morning Stiffness with Measures of Higher Disease Activity in a Large US Registry Population of Rheumatoid Arthritis Patients
Abstract Number: 422

Correlation of RAPID3, DAS28 and CDAI in Disease Activity and Effects of Education Level and Co-Morbid Diseases on This Assesment in RA
Abstract Number: 790

Correlations Between Histopathological Findings and Clinical Manifestations in a Large Monocentric Cohort of Patients with Biopsy-Proven Giant Cell Arteritis
Abstract Number: 2143

Cortical Breaks and Bone Erosions in the Hand Joints: A Cadaver Study Comparing Conventional Radiography with High-Resolution and Micro-Computed Tomography
Abstract Number: 925

Cortical Reorganization after Duloxetine Treatment-Related Pain Decrease in Knee Osteoarthritis
Abstract Number: 803

Corticosteroid-Related Adverse Events in Patients with Giant Cell Arteritis: A Claims-Based Analysis
Abstract Number: 688

Corticosteroids in Early Treatment Pathways in SLE
Abstract Number: 155

Cost-Effectiveness Analysis of HLA-B5801 Genotyping in the Treatment of Gout Patients with Chronic Renal Insufficiency in Korea
Abstract Number: 2338

Cost-Effectiveness and Yield of Different Recruitment Strategies Utilized in an Exercise Trial of Fibromyalgia Patients
Abstract Number: 1146

Cost-Effectiveness of Adalimumab for Rheumatoid Arthritis in Germany
Abstract Number: 2781

Cost-Effectiveness of Adding Etanercept Vs. Sulfasalazine and Hydroxychloroquine to Methotrexate Therapy: A Randomized Noninferiority Trial
Abstract Number: 2232

Cost-Effectiveness of Glucosamine, Chondroitin Sulfate, Their Combination, Celecoxib,Non-Selective Non-Steroidal Anti-Inflammatory Drugs, and Placebo in Treating Knee Osteoarthritis
Abstract Number: 2235

Cost-Effectiveness of Long-Term Opioid Use in the Treatment of Knee Osteoarthritis in Older Patients with Multiple Comorbidities
Abstract Number: 98

Costs of Musculoskeletal Diseases in the United States, 1996-2011: Population Growth, Population Aging, Health Care Utilization, or Prices?
Abstract Number: 2709

Could a Fibroblast-Free Environment Protect the Microcirculation in Systemic Sclerosis? Evidence from Retinal Vascular Imaging Research
Abstract Number: 395

Could Osteoprotegerin and TNF-Related Apoptosis-Inducing Ligand Assessments Help Us to Manage Early Rheumatoid Arthritis? Results from the Espoir Cohort
Abstract Number: 296

Countermeasures Against Methotrexate Intolerance in Juvenile Idiopathic Arthritis Instituted By Parents Show No Effect
Abstract Number: 101

Country of Residence and Its Wealth Determine Disease Activity Levels in RA: Results from Multi-National Study Across 17 Countries (COMORA)
Abstract Number: 2329

Course and Outcome of Rehabilitation Care in Different Rheumatological Diagnosis Groups. a Descriptive Study Using the STAR-Etic Registry
Abstract Number: 1511

COVA322: A Clinical Stage Bispecific TNF/IL-17A Inhibitor for the Treatment of Inflammatory Diseases
Abstract Number: 2249

Criteria for Clinically Important Worsening in Knee and Hip Osteoarthritis
Abstract Number: 1315

Cross-Sectional Evaluation of Hydroxychloroquine (HCQ) Therapy in Children with Juvenile Dermatomyositis (JDM) Enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry
Abstract Number: 1227

Cryopyrinopathy with a Myeloid-Specific NLRP3 Mutation
Abstract Number: 1966

CTLA4-Ig (abatacept) Modulate in Vitro the ICAM1 and VEGFR-2 Expression in Human Endothelial Cells
Abstract Number: 2144

Cuantification of Hand Bone Mineral Density By Radiogrammetry and Dual X-Ray Absorptiometry in Early Arthritis Patients
Abstract Number: 1525

Cumulative Clinical Â Response in Â RheumatoidÂ Arthritis Patients with Â Rituximab Repeated Courses after Failure to TumorÂ Necrosis Factor Inhibitors in RoutineÂ Clinical Practice Â
Abstract Number: 1582

Cumulative Inflammatory Burden Is Independently Associated with Increased Arterial Stiffness in Patients with Psoriatic Arthritis
Abstract Number: 1531

CUT-Off LEVEL of Adalimumab and Prevalence of Antibodies ANTI-Adalimumab in Patients with Ankylosing Spondylitis: Results from a LOCAL Registry
Abstract Number: 2775

Cutaneous Vasculitis Associated with Severe Bacterial Infections. Study of 27 Patients from a Series of 766 Cutaneous Vasculitis
Abstract Number: 521

CXCL13 Serum Levels Is Associated with Lymphoma, High B Cells Markers and Diseases activity in Primary Sjögren ’s Syndrome Patients
Abstract Number: 1704

CXCL4 Promotes Fibrosis By Increasing Expression of Extracellular Matrix Modifying Factors and By Facilitating Epithelial/Endothelial Mesenchymal Transition
Abstract Number: 2465

Cyclic Phosphatidic Acid (cPA) Suppresses MMP-3, a Disintegrin and Metalloproteinase with Thrombospondin Motifs(ADAMTS)-4, -5 and Stimulates HAS2 Expression in Inflammatory Rheumatoid Synovial Fibroblasts Induced with IL-1β and/or TNF-α
Abstract Number: 1640

Cyclophosphamide Diminishes Plasmablasts and Transitional B Cells and Suppresses Autocrine Production of B Cell Activating Factor of Tumor Necrosis Factor Family (BAFF) in These Cells in Patients with Systemic Lupus Erythematosus
Abstract Number: 316

Cytokines in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome: Tipping the Balance Between Interleukin-18 and Interferon-Gamma